◼ Archived
Business
Is my GLP-1 safe? What to know about FDA's crackdown on copycat drugs
FDA moves to curb bulk compounding of GLP‑1 weight‑loss drugs as legal action hits telehealth firm HIMS
Compounding
6 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Trump administration advances plan for peptide drugs favored by RFK Jr.
The Trump administration advances a policy initiative regarding peptide drugs, drawing widespread attention across multiple news outlets.
◼ Archived
Business
🔮 fades ✓
FDA Panel Backs 6 Peptides for Compounding
An FDA advisory panel has signaled support for easing restrictions on six specific peptides for compounding, sparking a debate over drug safety.
◼ Archived
Business
🔮 fades ✓
Hot Peptide Summer Is Almost Here
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 holds
A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda
An FDA advisory panel has voted to allow the compounding of unapproved peptides, signaling a potential conflict with agency scientists.
◼ Archived
Health
🔮 fades
FDA raised conflict of interest concerns ahead of new peptide panel
Federal regulators face mounting scrutiny over potential conflicts of interest ahead of an upcoming vote on peptide substances.